The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson's Disease Pathogenesis.

Parkinson’s disease dopaminergic neurons insulin resistance insulin signaling

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 22 06 2023
revised: 04 08 2023
accepted: 11 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Parkinson's disease (PD) is a degenerative condition resulting from the loss of dopaminergic neurons. This neuronal loss leads to motor and non-motor neurological symptoms. Most PD cases are idiopathic, and no cure is available. Recently, it has been proposed that insulin resistance (IR) could be a central factor in PD development. IR has been associated with PD neuropathological features like α-synuclein aggregation, dopaminergic neuronal loss, neuroinflammation, mitochondrial dysfunction, and autophagy. These features are related to impaired neurological metabolism, neuronal death, and the aggravation of PD symptoms. Moreover, pharmacological options that involve insulin signaling improvement and dopaminergic and non-dopaminergic strategies have been under development. These drugs could prevent the metabolic pathways involved in neuronal damage. All these approaches could improve PD outcomes. Also, new biomarker identification may allow for an earlier PD diagnosis in high-risk individuals. This review describes the main pathways implicated in PD development involving IR. Also, it presents several therapeutic options that are directed at insulin signaling improvement and could be used in PD treatment. The understanding of IR molecular mechanisms involved in neurodegenerative development could enhance PD therapeutic options and diagnosis.

Identifiants

pubmed: 37630775
pii: nu15163585
doi: 10.3390/nu15163585
pmc: PMC10458139
pii:
doi:

Substances chimiques

Dopamine VTD58H1Z2X
Insulins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cells. 2021 Feb 12;10(2):
pubmed: 33673034
JAMA Neurol. 2017 Jul 1;74(7):780-792
pubmed: 28586827
CNS Drugs. 2019 Feb;33(2):143-160
pubmed: 30687888
Front Mol Neurosci. 2021 Dec 20;14:788695
pubmed: 34987360
NPJ Parkinsons Dis. 2023 Jan 27;9(1):11
pubmed: 36707543
Brain. 2021 May 7;144(4):1127-1137
pubmed: 33895825
Sci Rep. 2021 Nov 2;11(1):21500
pubmed: 34728675
Neuroscience. 2014 Jan 3;256:72-82
pubmed: 24128992
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
JAMA. 2010 Apr 14;303(14):1410-8
pubmed: 20388897
Front Neurol. 2021 Jan 12;11:634490
pubmed: 33584526
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
Front Mol Neurosci. 2022 Aug 26;15:947191
pubmed: 36090250
Front Physiol. 2022 Aug 23;13:957968
pubmed: 36082218
Sci Rep. 2015 Jul 31;5:12531
pubmed: 26228656
Prog Brain Res. 2020;252:169-216
pubmed: 32247364
J Neurochem. 2009 Oct;111(1):192-203
pubmed: 19686384
Brain Pathol. 2010 May;20(3):640-5
pubmed: 20522089
Front Oncol. 2022 Jul 08;12:956225
pubmed: 35898867
Acta Neuropathol Commun. 2018 Feb 23;6(1):14
pubmed: 29471869
Exp Neurobiol. 2015 Sep;24(3):197-205
pubmed: 26412968
Int J Mol Sci. 2022 Jan 17;23(2):
pubmed: 35055183
J Pharmacol Exp Ther. 2002 Mar;300(3):958-66
pubmed: 11861804
Mol Neurobiol. 2020 Apr;57(4):1966-1977
pubmed: 31900863
Lancet Reg Health Am. 2022 Mar;7:None
pubmed: 35300390
Front Endocrinol (Lausanne). 2018 Oct 16;9:621
pubmed: 30386301
Cells. 2022 May 24;11(11):
pubmed: 35681426
J Neuroinflammation. 2012 Feb 28;9:44
pubmed: 22373413
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Clin Geriatr Med. 2020 Feb;36(1):1-12
pubmed: 31733690
Front Neurol. 2019 Mar 19;10:218
pubmed: 30941085
Diabetes Obes Metab. 2015 Apr;17(4):403-13
pubmed: 25580570
J Neurosci. 2010 Sep 15;30(37):12535-44
pubmed: 20844148
J Neural Transm Suppl. 2000;(58):143-51
pubmed: 11128604
PLoS One. 2012;7(10):e47387
pubmed: 23082161
Front Public Health. 2021 Dec 07;9:776847
pubmed: 34950630
Front Neurosci. 2020 Sep 23;14:547175
pubmed: 33100956
Expert Opin Drug Metab Toxicol. 2020 May;16(5):403-414
pubmed: 32238065
Life (Basel). 2021 Aug 09;11(8):
pubmed: 34440548
Int J Mol Sci. 2023 Mar 21;24(6):
pubmed: 36982988
Transl Neurodegener. 2019 Aug 16;8:23
pubmed: 31428316
Mov Disord. 2018 Sep;33(9):1449-1455
pubmed: 30145805
J Endocrinol. 2009 Sep;202(3):431-9
pubmed: 19570816
Front Neurosci. 2021 Aug 10;15:730378
pubmed: 34447295
Int J Mol Sci. 2022 Nov 03;23(21):
pubmed: 36362220
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1132-1146
pubmed: 27345267
Mol Neurodegener. 2021 Jul 2;16(1):44
pubmed: 34215308
Cell. 2011 Mar 4;144(5):689-702
pubmed: 21376232
Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E276-86
pubmed: 20858756
Neuron. 2008 Jan 24;57(2):178-201
pubmed: 18215617
Mov Disord. 2016 Sep;31(9):1422-3
pubmed: 27431803
Int J Mol Sci. 2020 Nov 17;21(22):
pubmed: 33212758
Acta Neuropathol. 2014 Dec;128(6):805-20
pubmed: 25296989
J Clin Invest. 2005 Dec;115(12):3587-93
pubmed: 16284649
Int J Mol Sci. 2021 Jul 16;22(14):
pubmed: 34299248
J Parkinsons Dis. 2018;8(2):161-181
pubmed: 29614701
Neuron. 2019 Aug 21;103(4):627-641.e7
pubmed: 31255487
Expert Opin Investig Drugs. 2020 Apr;29(4):333-348
pubmed: 32175781
Diabet Med. 2005 Jun;22(6):674-82
pubmed: 15910615
J Mol Neurosci. 2013 Nov;51(3):911-8
pubmed: 23979838
Nat Rev Drug Discov. 2018 Nov;17(11):804-822
pubmed: 30262889
Nutr Neurosci. 2021 Oct;24(10):810-834
pubmed: 31684843
Inflammopharmacology. 2017 Jun;25(3):369-382
pubmed: 28258522
Biochem J. 2004 Feb 1;377(Pt 3):709-16
pubmed: 14565847
Front Aging Neurosci. 2018 Nov 22;10:370
pubmed: 30524265
Neurosci Lett. 2001 Jan 19;297(3):191-4
pubmed: 11137760
Alzheimers Res Ther. 2021 Feb 17;13(1):47
pubmed: 33597002
J Parkinsons Dis. 2020;10(2):355-368
pubmed: 32250322
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
NPJ Parkinsons Dis. 2020 Jul 9;6:15
pubmed: 32665974
NPJ Parkinsons Dis. 2021 Mar 10;7(1):27
pubmed: 33692356
Int J Mol Sci. 2021 Dec 30;23(1):
pubmed: 35008822
Nat Rev Neurosci. 2011 Nov 03;12(12):723-38
pubmed: 22048062
Cells. 2022 Sep 17;11(18):
pubmed: 36139483
Front Genet. 2019 May 14;10:435
pubmed: 31139208
Sci Rep. 2022 Feb 7;12(1):2038
pubmed: 35132125
Front Cell Dev Biol. 2020 Dec 18;8:599792
pubmed: 33392190
J Clin Invest. 2009 Jan;119(1):182-92
pubmed: 19104149
Transl Neurodegener. 2022 Mar 7;11(1):14
pubmed: 35255986
Nutrients. 2022 Oct 25;14(21):
pubmed: 36364733
Cell Death Dis. 2021 Aug 17;12(9):796
pubmed: 34404758
Front Endocrinol (Lausanne). 2018 Nov 02;9:608
pubmed: 30450079
Cell Death Differ. 2021 Feb;28(2):570-590
pubmed: 33414510
Nat Rev Immunol. 2022 Nov;22(11):657-673
pubmed: 35246670
Front Immunol. 2022 May 18;13:878771
pubmed: 35663989
Balkan Med J. 2022 Aug 29;39(5):318-333
pubmed: 36036436
Neurosci Lett. 2010 Dec 17;486(3):235-9
pubmed: 20887775
Curr Opin Struct Biol. 2013 Feb;23(1):82-9
pubmed: 23266002
Neuropharmacology. 2013 Apr;67:243-51
pubmed: 23196068
J Neurosci Res. 2021 Nov;99(11):2932-2947
pubmed: 34510532
Int J Mol Sci. 2019 Feb 18;20(4):
pubmed: 30781611
Diabetes. 2002 Dec;51(12):3384-90
pubmed: 12453890
PLoS One. 2016 Mar 11;11(3):e0150552
pubmed: 26967642
J Neurol Sci. 2012 Apr 15;315(1-2):39-43
pubmed: 22265943
Front Neurosci. 2019 May 22;13:491
pubmed: 31231176
Neurotox Res. 2020 Mar;37(3):491-507
pubmed: 31823227
Neurology. 2009 Nov 24;73(21):1752-8
pubmed: 19933976
Front Physiol. 2019 May 03;10:532
pubmed: 31130874
Mol Psychiatry. 2023 Jan;28(1):217-229
pubmed: 36258018
Neurobiol Dis. 2020 Oct;144:105028
pubmed: 32736085
Front Neurosci. 2019 Oct 18;13:1112
pubmed: 31680842
Front Pharmacol. 2020 Apr 23;11:356
pubmed: 32390826
Front Neurosci. 2019 Apr 11;13:328
pubmed: 31031582
J Mov Disord. 2015 May;8(2):92-7
pubmed: 26090081
PLoS Genet. 2012 Feb;8(2):e1002488
pubmed: 22319455
Brain. 2020 May 1;143(5):1462-1475
pubmed: 32380543
Front Neurosci. 2020 Dec 14;14:614828
pubmed: 33381011
Prog Neurobiol. 2016 Oct - Nov;145-146:98-120
pubmed: 27713036
Diabetes Obes Metab. 2016 Aug;18(8):747-54
pubmed: 27097743
Nutrients. 2023 Jun 13;15(12):
pubmed: 37375632
J Parkinsons Dis. 2014;4(3):337-44
pubmed: 24662192
Int J Obes Relat Metab Disord. 2003 Mar;27(3):313-8
pubmed: 12629557
Nat Med. 2017 Sep 8;23(9):1018-1027
pubmed: 28886007
Brain Res. 2015 Dec 2;1628(Pt B):247-253
pubmed: 26080075
Diabetologia. 2022 Aug;65(8):1375-1389
pubmed: 35652923
Lancet. 2017 Oct 7;390(10103):1664-1675
pubmed: 28781108
NPJ Parkinsons Dis. 2017 Jan 23;3:4
pubmed: 28649604
Front Genet. 2022 Mar 01;13:781816
pubmed: 35299952
Free Radic Biol Med. 2021 Nov 20;176:16-33
pubmed: 34530075
J Clin Invest. 1996 Jan 1;97(1):258-62
pubmed: 8550844
Front Immunol. 2018 Sep 27;9:2047
pubmed: 30319601
NPJ Parkinsons Dis. 2022 Mar 2;8(1):19
pubmed: 35236852
Ann N Y Acad Sci. 2015 Sep;1350:37-47
pubmed: 26121488
Expert Rev Mol Med. 2011 Mar 21;13:e8
pubmed: 21418705
Cells. 2022 Nov 19;11(22):
pubmed: 36429110
Nat Rev Neurol. 2019 Aug;15(8):437-438
pubmed: 31152151
Aging Dis. 2022 Dec 1;13(6):1591-1605
pubmed: 36465171
Nat Rev Neurol. 2020 Jun;16(6):303-318
pubmed: 32332985
Sci Rep. 2016 Jul 18;6:29967
pubmed: 27426254
Diabetes. 2011 Jan;60(1):227-38
pubmed: 20980462
Acta Neuropathol. 2021 Apr;141(4):527-545
pubmed: 33555429
Neural Regen Res. 2023 May;18(5):1099-1106
pubmed: 36254999
Future Neurol. 2012 Nov;7(6):733-748
pubmed: 23144589
Cells. 2020 Mar 17;9(3):
pubmed: 32192190
Neurochem Res. 2015 Feb;40(2):308-16
pubmed: 25007880
Front Aging Neurosci. 2022 Jun 20;14:885500
pubmed: 35795234
Neurosci Lett. 2021 Apr 1;749:135754
pubmed: 33610666
Behav Brain Res. 2023 Mar 28;442:114309
pubmed: 36706808
Drug Discov Today. 2016 May;21(5):802-18
pubmed: 26851597
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a009373
pubmed: 22951445
Endocrinology. 2020 Apr 1;161(4):
pubmed: 32060542
NPJ Parkinsons Dis. 2015;1:
pubmed: 27148593
J Parkinsons Dis. 2020;10(3):775-789
pubmed: 32333549
Int J Environ Res Public Health. 2020 Jul 03;17(13):
pubmed: 32635358
Neuroscience. 2015 Sep 10;303:42-50
pubmed: 26141845
Front Neurosci. 2018 Feb 20;12:73
pubmed: 29515352
Front Neurosci. 2019 Aug 16;13:868
pubmed: 31474827
J Cell Biochem. 2016 Apr;117(4):917-26
pubmed: 26364587
Biol Pharm Bull. 2010;33(7):1165-9
pubmed: 20606308
Neuroscience. 2007 Jul 29;147(4):867-83
pubmed: 17459594
J Clin Invest. 1993 Sep;92(3):1288-95
pubmed: 8376587
Front Pharmacol. 2021 Apr 15;12:648636
pubmed: 33935751
Int J Mol Sci. 2018 Sep 09;19(9):
pubmed: 30205618
Cells. 2020 Jul 14;9(7):
pubmed: 32674367

Auteurs

Viviana A Ruiz-Pozo (VA)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Rafael Tamayo-Trujillo (R)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Santiago Cadena-Ullauri (S)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Evelyn Frias-Toral (E)

School of Medicine, Universidad Católica Santiago de Guayaquil, Guayaquil 090615, Ecuador.

Patricia Guevara-Ramírez (P)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Elius Paz-Cruz (E)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Sebastián Chapela (S)

Departamento de Bioquímica, Facultad de Ciencias Médicas, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1121ABE, Argentina.
Equipo de Soporte Nutricional, Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires C1280AEB, Argentina.

Martha Montalván (M)

School of Medicine, Universidad Espíritu Santo, Samborondón 091952, Ecuador.

Tania Morales-López (T)

Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Daniel Simancas-Racines (D)

Centro de Investigación de Salud Pública y Epidemiología Clínica (CISPEC), Universidad UTE, Quito 170527, Ecuador.

Ana Karina Zambrano (AK)

Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH